… drugmaker Sanofi abruptly ousted its CEO Paul Hudson on Thursday, … ⁠KGaA, as ⁠its new chief executive, adding she would take over … lower than UK-based rivals AstraZeneca and GSK, which saw returns … Charmeil will serve as acting CEO during the transition. Garijo …

… Thursday announced the ouster of CEO Paul Hudson after a six … replaced by current Merck KGaA CEO Belén Garijo, who is leaving … medicines, will serve as interim CEO after Hudson’s departure at … rivals such as Novartis and AstraZeneca have seen their shares or …

… mengumumkan pengangkatan Michael Cola sebagai Chief Executive Officer, yang segera berlaku. … berbagai posisi pemimpin senior di AstraZeneca PLC, mendukung perluasan siklus hidup … Cola menjabat sebagai Presiden dan CEO Avalo Therapeutics, Inc., tempatnya …

… Ernennung von Michael Cola zum Chief Executive Officer mit sofortiger Wirkung … Er bekleidete später Führungsrollen bei AstraZeneca PLC hinsichtlich der Lebenszykluserweiterung von … fungierte Cola als President und CEO von Avalo Therapeutics, Inc., …

… Sanofi, will serve as interim CEO during the transition as Hudson … her five-year tenure as chief executive at the end of April … s pharmaceutical department, Garijo became CEO at Merck KGaA back in … Jefferies team said, pointing to AstraZeneca's four years of …

… drugmaker Sanofi abruptly ousted its CEO Paul Hudson on Thursday, underscoring … well below UK-based rivals AstraZeneca and GSK, which returned 133% … Charmeil will serve as acting CEO during the transition. Garijo previously …

… AI-driven discovery platform. AstraZeneca gets exclusive global rights … asset in the CSPC-AstraZeneca collaboration, is already off … partnership between CSPC and AstraZeneca began swirling, driving the … of vice chairman and chief executive officer at the firm …

… has removed Paul Hudson as chief executive, thanking him Thursday for … . Belen Garijo, currently chief executive of Germany’s Merck … stints at Novartis and AstraZeneca.  His removal came less … from places like AstraZeneca,” the Jefferies analysts said …

… paused £200m investment in Cambridge. AstraZeneca’s chief executive, Pascal Soriot, suggested that … been much higher than elsewhere. AstraZeneca ditched a planned £450m expansion … recognised”. His remarks came as AstraZeneca forecast steady sales and profit …

… at Astra-Merck and AstraZeneca PLC Proven leader in … of Michael Cola as Chief Executive Officer, effective immediately. Mr … senior leadership roles at AstraZeneca PLC supporting the lifecycle … Cola served as President and CEO of Avalo Therapeutics, Inc …